跳至主要内容
临床试验/DRKS00016024
DRKS00016024已完成不适用

Phase 1-3 development of an EORTC module assessing fertility issues and patient care needs - EORTC - Fertility

Interdisziplinäres Tumorzentrum - CCCF - Stiftungsprofessur Selbsthilfeforschung0 个研究点目标入组 82 人开始时间: 2020年2月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients are eligible if they have / are
  • signed the written informed consent to participate in the study
  • a primary diagnosis of
  • o gynaecological cancer
  • o bladder cancer
  • o colorectal cancer
  • o testicular cancer
  • o prostate cancer
  • o breast cancer
  • o sarcoma and
  • Female patients > 18 years to 42 years
  • Female patients in pre-menopause
  • Male patients > 18 years
  • Patients in any treatment with curative intention affecting fertility, focusing on
  • o Systemic therapy
  • o Radiotherapy
  • o Combined therapy (radiation, surgery, systemic treatment)

排除标准

  • Patients with other than the above mentioned diagnoses and treatments, that are contradictionnairy to the inclusion criteria

研究者

发起方
Interdisziplinäres Tumorzentrum - CCCF - Stiftungsprofessur Selbsthilfeforschung

相似试验